Showing 901-910 of 3315 results for "".
Harrow Adds Biosimilars to US Portfolio
https://modernod.com/podcasts/eyewire-news-the-podcast/harrow-adds-biosimilars-to-us-portfolio/37094/Harrow enters a deal to expand it biosimilar pharma portfolio; the first gene-agnostic therapy to restore vision in RP patients advances; and Aldeyra provides an update on its dry eye drug candidate reproxalap. Learn more about your ad choices. Visit megaphone.fm/adchoicesAECOS Presentation Summaries
https://modernod.com/podcasts/eyewire-news-the-podcast/aecos-presentation-summaries/37093/Leading ophthalmologists share summaries of their presentations live from thee AECOS Summer Symposium. Learn more about your ad choices. Visit megaphone.fm/adchoicesB+L Receives Approval in Europe for LuxLife IOL
https://modernod.com/podcasts/eyewire-news-the-podcast/bl-receives-approval-in-europe-for-luxlife-iol/37084/Bausch + Lomb receives CE Mark for a new full range of vision IOL; Aldeyra plans to once again resubmit a new drug application to the FDA for dry eye drug candidate reproxalap; and Topcon makes several deals to advance its AI and digital health solutions Learn more about your ad choices. Visit megOculomics • IPL & Ocular Rosacea
https://modernod.com/podcasts/the-mod-pod/oculomics-ipl-ocular-rosacea/36881/Join Cecelia Koetting, OD, FAAO, Dipl ABO, on this month's episode of The MOD Pod as she learns about how imaging and biomarkers can be used to diagnose, manage, and treat ocular and systemic conditions (aka oculomics) from Modern Optometry contributor Shane Kannarr, OD. Dr. Koetting's second guestBreaking News from the ASCRS Meeting in Los Angeles
https://modernod.com/podcasts/eyewire-news-the-podcast/breaking-news-from-the-ascrs-meeting-in-los-angeles/37082/EyewireTV reports on new products and breaking news live from the American Society of Cataract and Refractive Surgery (ASCRS) meeting in Los Angeles. Learn more about your ad choices. Visit megaphone.fm/adchoicesAlcon Voyager DSLT Fully Launched in US
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-voyager-dslt-fully-launched-in-us/37072/Alcon launches the first DSLT device in thee US; the FDA approves an expanded label for Astellas Pharma's geographic atrophy drug Izervay; and New World Medical received FDA clearance for the VIA360 Surgical System. Learn more about your ad choices. Visit megaphone.fm/adchoicesAAO Opposes NIH Research Funding Proposal
https://modernod.com/podcasts/eyewire-news-the-podcast/aao-opposes-nih-research-funding-proposal/37071/The AAO responds to a proposal by the NIH to limit indirect funding for research projects; Lumenis launches a new device to address lower lid laxity and impaired blinking; and AI Optics receives FDA clearance for a handheld retinal imaging system. Learn more about your ad choices. Visit megaphone.fmSpecial Report – Increasing Access to Care Through the Cure Blindness Project
https://modernod.com/podcasts/eyewire-news-the-podcast/special-report-increasing-access-to-care-through-the-cure-blindness-project/37067/Leaders from Cure Blindness Project discuss efforts to restore vision and prevent avoidable blindness in underserved communities around the world. Learn more about your ad choices. Visit megaphone.fm/adchoicesB+L Bolsters Glaucoma Offerings with Elios Acquisition
https://modernod.com/podcasts/eyewire-news-the-podcast/bl-bolsters-glaucoma-offerings-with-elios-acquisition/37063/Bausch + Lomb makes an acquisition to expand its glaucoma offerings; Roche gets a major approval in Europe for Vabysmo; and EssilorLuxottica buys a maker of noninvasive ophthalmic medical devices. Learn more about your ad choices. Visit megaphone.fm/adchoicesTactics for Effective Communication With Patients
https://modernod.com/topics/business/tactics-for-effective-communicationwith-patients/37948/Fine-tuning your communication skills can lead to better outcomes through increased compliance.